Adolescent idiopathic scoliosis (AIS) is a progressive lateral and rotational curvature of the spine occurring in patients aged approximately 10–18 years and is defined radiographically by a Cobb Angle of at least 10°. Progressive curves that reach the surgical range in adolescence are associated with long‑term sequelae including pulmonary compromise, disability, pain, and reduced quality of life if left untreated; curves that exceed skeletal maturity (≈ >40°–45°) are likely to progress into adulthood (AIS natural history and risks). [[9],[10]]
Vertebral body tethering (VBT) is a fusion‑sparing, growth‑modulation surgical technique performed by an anterior thoracotomy, thoracoscopic, or mini‑open approach. The procedure secures vertebral body screws and tensioned flexible cords across the convex side of the curve so that asymmetric loading slows growth on the compressed side while allowing continued growth on the convex side, with the goal of correcting deformity while preserving spinal motion. VBT may use single or double cords and can be applied to thoracic, thoracolumbar, or lumbar curves; revision to replace, remove, or augment hardware is sometimes required for complications or inadequate correction. [[9],[18]]
Compared with the conventional standard of care, posterior spinal fusion (PSF), VBT offers potential advantages reported in many series including better preservation of spinal range of motion, reduced estimated blood loss, shorter instrumentation levels, and faster early recovery. However, comparative studies and pooled reviews also show less reliable and smaller radiographic curve correction, and substantially higher rates of mechanical complications, reoperation, and conversion to fusion in many series. Systematic reviews and meta‑analyses report mean Cobb reductions at ~two years but an overall complication rate in the range of ~20–30% and tether breakage reported variably across studies (single‑study and pooled estimates range broadly); conversion to PSF and reoperation rates are consistently higher than for PSF. These tradeoffs are central to candidate selection and counseling. [[14],[13],[44],[46]]
Clinical evidence for VBT is evolving and is largely composed of prospective registries, single‑center cohorts, and retrospective comparative series with limited long‑term follow‑up to skeletal maturity. Some prospective studies (for example FDA IDE and other multicenter cohorts) report short‑term clinical success (e.g., ~75% success at two years by the IDE study definition of Cobb <35° and no reoperation), but larger series and registry data document increasing tether breakage and reoperation rates with longer follow‑up (Kaplan–Meier estimates and multi‑center reports show substantive increases by 24–36 months and beyond). Reported pulmonary and perioperative complications (pleural effusion, chylothorax, pneumothorax) and device‑mechanical failures are notable and can be more common than with PSF in some reports. Overall evidence quality is low‑to‑moderate and longer‑term, comparative, multicenter data to skeletal maturity are limited. [[18],[19],[35],[36],[44]]